Biotechnology company Vical Inc. said on Tuesday the National Institutes of Health has started a midstage trial of an experimental vaccine for HIV, the virus that causes AIDS.
Biotechnology company Vical Inc. said on Tuesday the National Institutes of Health has started a midstage trial of an experimental vaccine for HIV, the virus that causes AIDS.
No Responses to “HIV vaccine advances to midstage trial”
Please Wait
Leave a Reply